Phase 3 Lupus Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 6 and 18 years old (including those who are exactly 6 or 18)
- You have been diagnosed with Systemic Lupus Erythematosus (SLE) based on recognised 2019 international guidelines
- You have been diagnosed with an active, serious form of lupus affecting the kidneys (called lupus nephritis, Class III or IV), confirmed by a kidney biopsy taken within the last 6 months
- Your lupus disease activity score is at a certain level of severity (SLEDAI-2000 score of 8 or higher) (confirm with trial site)
- Your lupus nephritis has not responded well to treatment — meaning you have tried two or more immune-suppressing medications for more than 6 months without the disease going into remission, or it came back after remission, and you still have protein in your urine
- A blood test has shown that a certain type of immune cell called CD19 B cells is present in your blood
- You have suitable veins and no medical reason preventing collection of your blood cells
- You and your parent or guardian are willing to give written consent and take part voluntarily
- Your blood cell counts meet certain minimum levels (for example, your white blood cells, infection-fighting cells, and haemoglobin are above set thresholds) (confirm with trial site)
- Your liver is functioning within acceptable limits based on blood tests (confirm with trial site)
- Your kidneys are still functioning at a certain minimum level, as measured by a calculation called eGFR (at least 30 ml/min/1.73m²)
- Your blood clotting results are within acceptable limits (confirm with trial site)
- Your heart is stable
- A specific lupus-related antibody called ANA is present at a level of 1:80 or higher in your blood
- Your general physical ability is rated between 0 and 2 on a standard scale (meaning you are able to carry out everyday activities, possibly with some limitations) (confirm with trial site)
Who may not be able to join:
- You have previously had a kidney transplant
- You have a history of serious allergic reactions to medications
- You currently have an active infection (fungal, bacterial, viral, or other) that is not under control or needs treatment
- You have serious problems with your heart, liver, lungs, or blood clotting
- You were born with a condition that means your body cannot produce enough antibodies (congenital immunoglobulin deficiency)
- You have active Hepatitis B, active Hepatitis C, HIV, or syphilis
- You have been diagnosed with cancer at any point in the last five years
- You have a serious disease of the brain or nervous system, a serious mental illness, or significant problems with thinking or memory
- You have taken part in another clinical trial within the past 3 months
- You have previously received a type of treatment called CAR-T cell therapy
- The trial doctors decide there is another reason that makes participation unsuitable for you
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 86+020-81330569
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of participants with CAR-T cells treatment-related adverse events(AE)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.